Scholarly Index
Gian Luca Salvagno
University of Verona; 15,567 total citations; 434 total publications; best world rank #11
University of Verona
15,567Total citations
434Total publications
60H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Clinical Laboratory Practices and Quality Control | Lifetime | 11 | IT 4 | 99.00 |
| Inflammatory Biomarkers in Disease Prognosis | Lifetime | 136 | IT 22 | 96.44 |
| COVID-19 Clinical Research Studies | Lifetime | 760 | IT 85 | 97.34 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 758 | IT 33 | 97.60 |
| SARS-CoV-2 detection and testing | Lifetime | 385 | IT 19 | 94.19 |
| Blood properties and coagulation | Lifetime | 502 | IT 24 | 95.62 |
| Hemophilia Treatment and Research | Lifetime | 432 | IT 37 | 94.95 |
| Blood transfusion and management | Lifetime | 599 | IT 15 | 92.84 |
| Meta-analysis and systematic reviews | Lifetime | 743 | IT 15 | 92.00 |
| Biosimilars and Bioanalytical Methods | Lifetime | 839 | IT 38 | 89.70 |
| Reliability and Agreement in Measurement | Lifetime | 170 | IT 6 | 85.87 |
| COVID-19 Clinical Research Studies | 2021-2025 | 811 | IT 87 | 96.64 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 884 | IT 46 | 96.69 |
| SARS-CoV-2 detection and testing | 2021-2025 | 482 | IT 22 | 91.83 |
| Heparin-Induced Thrombocytopenia and Thrombosis | 2021-2025 | 727 | IT 61 | 60.35 |
| Clinical Laboratory Practices and Quality Control | 2021-2025 | 554 | IT 24 | 44.19 |